In-Vitro Diagnostics Packaging Market Size & Growth Forecast 2027–2036, By Segments (End User, Product, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
In-Vitro Diagnostics Packaging Market size was assessed at USD 8.92 Billion in 2026 and is poised to grow at 5.83% CAGR between 2027 and 2036, exceeding USD 15.72 Billion by 2036. The industry revenue for 2027 is calculated at USD 9.36 Billion.
Get more details on this report
Request Free Sample ReportIn-Vitro Diagnostics Packaging Market Intelligence Snapshot
Regional Market Dynamics
- North America held 37.8% in 2026, supported by advanced diagnostic infrastructure, high laboratory testing utilization, and strong requirements for safe, reliable product packaging.
- Asia Pacific is projected to grow fastest as healthcare access, diagnostic testing, laboratory infrastructure, and domestic pharmaceutical and diagnostics manufacturing continue expanding.
Segment Momentum
- Hospitals lead the market because they perform high volumes of diagnostic testing and require dependable packaging to maintain sample integrity, support efficient workflows, and ensure safe handling across diverse healthcare services.
- Oncology is the fastest-growing application segment due to increasing demand for cancer screening, detection, and monitoring, where reliable packaging helps preserve specimen quality throughout diagnostic testing workflows.
Market Expansion Drivers
- Rising infectious disease testing volumes increasing demand for sterile diagnostic packaging solutions
- Expansion of point-of-care and home-based testing accelerating compact diagnostic kit packaging demand
- Cold chain expansion for temperature-sensitive diagnostics driving advanced protective packaging systems
Leading Market Participants
- Prominent companies in the in-vitro diagnostics packaging market include Amcor plc (Switzerland), AptarGroup, Inc. (United States), Corning Incorporated (United States), Greiner AG (Austria), Gerresheimer AG (Germany), Schott AG (Germany), Becton, Dickinson and Company (United States), Thermo Fisher Scientific Inc. (United States), Berry Global Group, Inc. (United States), West Pharmaceutical Services, Inc. (United States)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 8.92 Billion
- 2027 Estimated Market Size: USD 9.36 Billion
- Projected Market Size: USD 15.72 Billion by 2036
- Growth Forecast: 5.83% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End User) | Bottles and Vials (Product) | Infectious Diseases (Application)
- Emerging Opportunity Segment: Laboratories (End User) | Tubes (Product) | Oncology (Application)
Market Growth Drivers and Industry Trends
Rising infectious disease testing volumes increasing demand for sterile diagnostic packaging solutions
Growing testing activity for infectious diseases is driving the in-vitro diagnostics packaging market as diagnostic manufacturers require sterile and contamination-resistant packaging to preserve the integrity of test kits and reagents. Packaging solutions must protect sensitive components throughout manufacturing, transportation, and storage while ensuring reliable performance at the point of use. This increasing emphasis on product safety encourages the adoption of high-barrier materials and secure packaging designs that support stringent quality and regulatory requirements across diagnostic applications.
Expansion of point-of-care and home-based testing accelerating compact diagnostic kit packaging demand
The widespread adoption of decentralized diagnostic services is expected to propel the in-vitro diagnostics packaging market by increasing demand for compact, user-friendly packaging formats. Point-of-care and home-based testing kits require packaging that enables convenient handling, protects sensitive contents, and simplifies storage and transportation without compromising product performance. Manufacturers are therefore developing space-efficient packaging solutions that enhance usability while supporting safe distribution through healthcare facilities, pharmacies, and direct-to-consumer channels.
Cold chain expansion for temperature-sensitive diagnostics driving advanced protective packaging systems
The growing distribution of temperature-sensitive diagnostic products is strengthening the in-vitro diagnostics packaging market through increased demand for specialized protective packaging capable of maintaining product stability during transit. Advanced insulation materials, temperature-control solutions, and shock-resistant packaging help safeguard sensitive reagents and biological components against environmental fluctuations. These packaging systems also support reliable logistics across extended supply chains where maintaining product integrity is essential for accurate diagnostic performance.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising infectious disease testing volumes increasing demand for sterile diagnostic packaging solutions | 2% | High | North America, Europe, Asia Pacific | High | Near Term |
| Expansion of point-of-care and home-based testing accelerating compact diagnostic kit packaging demand | 1.8% | High | North America, Asia Pacific | High | Near Term |
| Cold chain expansion for temperature-sensitive diagnostics driving advanced protective packaging systems | 1.6% | Moderate | Europe, North America | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the in-vitro diagnostics packaging market, North America held the largest share of 37.8% in 2026, underpinned by its advanced diagnostic infrastructure, high utilization of laboratory testing, and strong demand for packaging solutions that preserve the integrity and safety of diagnostic products. The region's established healthcare systems support widespread adoption of in-vitro diagnostic technologies across hospitals, laboratories, research facilities, and point-of-care settings, increasing the need for reliable packaging designed to protect sensitive reagents, specimens, and diagnostic components. Stringent quality and safety expectations also encourage manufacturers to prioritize packaging performance, sterility, traceability, and product protection throughout storage and distribution.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is projected to register the fastest growth, supported by expanding healthcare access, increasing diagnostic testing, and continued development of laboratory and medical infrastructure. Rising awareness of early disease detection is encouraging greater use of diagnostic technologies, while investments in healthcare facilities and laboratory capacity are broadening the addressable demand for specialized packaging. The expansion of domestic pharmaceutical and diagnostics manufacturing is also contributing to the need for packaging formats that meet increasingly sophisticated protection and handling requirements. At the same time, improvements in healthcare delivery across emerging economies are creating additional opportunities for packaging suppliers serving both centralized laboratories and decentralized testing environments.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Regulatory Packaging FocusThe U.S. prioritizes in-vitro diagnostics packaging that supports regulatory compliance, sterile protection, and efficient logistics for diverse testing applications. Demand centers on packaging formats that improve traceability, automation compatibility, and secure transport across clinical and laboratory networks.
Germany 🇩🇪
Precision Manufacturing SupportGermany emphasizes high-quality in-vitro diagnostics packaging aligned with precision manufacturing and stringent quality assurance practices. Manufacturers focus on durable materials, contamination control, and packaging consistency to support advanced diagnostic production and export requirements.
Japan 🇯🇵
Compact Diagnostic SolutionsJapan favors compact and highly functional in-vitro diagnostics packaging that accommodates sophisticated diagnostic devices and limited laboratory space. Packaging development prioritizes product integrity, ease of handling, and compatibility with automated laboratory workflows.
South Korea 🇰🇷
Innovation-Ready PackagingSouth Korea advances in-vitro diagnostics packaging through investments in biotechnology and modern diagnostic manufacturing. Packaging suppliers emphasize flexible designs, barrier performance, and efficient production methods that support rapid product commercialization and international distribution.
France 🇫🇷
Quality Assurance PackagingFrance places strong emphasis on in-vitro diagnostics packaging that safeguards sensitive diagnostic products throughout storage and transportation. Market priorities include validated packaging systems, sustainable material choices, and compliance with healthcare quality standards.
Italy 🇮🇹
Specialized Medical PackagingItaly supports the in-vitro diagnostics packaging market through specialized packaging capabilities serving medical and laboratory applications. Companies focus on customized formats, reliable protective performance, and production flexibility for diverse diagnostic product portfolios.
Segment Leadership and Growth Trends
In-Vitro Diagnostics Packaging Market Share (%), by End User, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd User Segment Analysis: Hospitals (Largest Segment) vs Laboratories (Fastest-Growing Segment)
Hospitals represented the largest end-user segment of the in-vitro diagnostics packaging market in 2026, supported by their extensive use of diagnostic testing across routine care, emergency services, disease monitoring, and specialized treatment. Hospitals require a broad range of packaged diagnostic products to maintain sample integrity, support efficient testing workflows, and ensure safe handling of diagnostic materials. The high volume and diversity of testing activities performed in hospital environments have reinforced their leading position within the market.
Laboratories are expected to be the fastest-growing end-user segment, driven by the increasing demand for specialized diagnostic testing and expanding laboratory-based healthcare services. Laboratories rely on dependable packaging formats to preserve sample quality, facilitate handling, and support accurate testing processes. Growing adoption of advanced diagnostic techniques, research-based testing, and decentralized laboratory services is creating additional demand for specialized in-vitro diagnostics packaging solutions.
Product Segment Analysis: Bottles and Vials (Largest Segment) vs Tubes (Fastest-Growing Segment)
Bottles and vials held the largest share of the in-vitro diagnostics packaging market in 2026, supported by their broad use for storing reagents, specimens, and other diagnostic materials. These formats provide practical solutions for containment, transport, and controlled handling across a range of testing workflows. Their established use in healthcare and laboratory environments, combined with their compatibility with different diagnostic materials, has supported continued demand and reinforced their leading position.
Tubes are anticipated to be the fastest-growing product segment, supported by increasing demand for convenient sample collection, storage, and processing formats. Tubes are well suited to laboratory workflows that require efficient handling and compatibility with automated testing systems. The growing emphasis on streamlined diagnostics, higher testing efficiency, and improved sample management is encouraging wider adoption of tube-based packaging solutions.
Application Segment Analysis: Infectious Diseases (Largest Segment) vs Oncology (Fastest-Growing Segment)
Infectious diseases represented the largest application segment of the in-vitro diagnostics packaging market in 2026. Diagnostic testing plays a central role in identifying and monitoring infectious conditions, creating sustained demand for packaging that supports the safe collection, preservation, and handling of samples and reagents. The need for efficient disease detection and ongoing monitoring across healthcare and laboratory settings continues to support high utilization of diagnostic packaging for infectious disease applications.
Oncology is expected to be the fastest-growing application segment, driven by increasing demand for diagnostic testing throughout cancer screening, detection, classification, and monitoring. Oncology diagnostics often require precise sample handling and reliable packaging to preserve specimen integrity during testing workflows. The growing emphasis on early detection, personalized treatment planning, and advanced diagnostic evaluation is supporting greater demand for specialized in-vitro diagnostics packaging in oncology applications.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End User | Hospitals, Laboratories, Academic Institutes, Others | Hospitals | Laboratories |
| Product | Bottles and Vials, Tubes, Petri Dishes, Closures, Others | Bottles and Vials | Tubes |
| Application | Diabetes, Infectious Diseases, Cardiology, Autoimmune Diseases, Oncology, Drug Testing, Others | Infectious Diseases | Oncology |
Competitive Landscape and Market Positioning
Leading companies in the in-vitro diagnostics packaging market:
- Amcor plc (Switzerland)
- AptarGroup, Inc. (United States)
- Corning Incorporated (United States)
- Greiner AG (Austria)
- Gerresheimer AG (Germany)
- Schott AG (Germany)
- Becton Dickinson and Company (United States)
- Thermo Fisher Scientific, Inc. (United States)
- Berry Global Group, Inc. (United States)
- West Pharmaceutical Services, Inc. (United States)
Evolving diagnostic technologies are reshaping competitive priorities in the in-vitro diagnostics packaging market, where suppliers are expected to protect increasingly sensitive reagents and biological materials throughout storage and transportation. Manufacturers are refining barrier materials, contamination control features, and precision packaging formats to preserve product integrity while supporting automated laboratory workflows. Another notable shift is the growing demand for customized packaging solutions tailored to specialized diagnostic kits, encouraging closer collaboration between packaging developers and healthcare manufacturers during product design. This environment places greater emphasis on technical expertise, regulatory readiness, and consistent manufacturing quality than on standardized packaging production alone.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Amcor plc (Switzerland) | |||||||
| AptarGroup Inc. (United States) | |||||||
| Corning Incorporated (United States) | |||||||
| Greiner AG (Austria) | |||||||
| Gerresheimer AG (Germany) | |||||||
| Schott AG (Germany) | |||||||
| Becton Dickinson and Company (United States) | |||||||
| Thermo Fisher Scientific Inc. (United States) | |||||||
| Berry Global Group Inc. (United States) | |||||||
| West Pharmaceutical Services Inc. (United States) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Corning | Aug-25 | Corning achieved mechanical completion on its USD 500 million North Carolina glass tubing expansion project. This manufacturing enhancement adds an estimated 150 million vial capacity dedicated to molecular diagnostics, significantly strengthening domestic supply chain resilience and production scale. |
| AptarGroup Incorporated | Jul-25 | AptarGroup Incorporated acquired the clinical trial materials manufacturing capabilities of Mod3 Pharma, integrating cGMP fill-finish services into its operational portfolio. This transaction expands Aptar's technical footprint in drug delivery and secondary packaging, supporting advanced diagnostic and therapeutic product workflows. |
| Greiner Bio-One | May-25 | Greiner Bio-One doubled its production capacity for VACUETTE CAT tubes at its Kremsmuenster manufacturing facility. This operational expansion directly targets growing regional demand in Southeast Asia for specialized gel-barrier sample collection formats. |
| SGD Pharma | Feb-24 | SGD Pharma introduced a new range of Type I tubular glass injectable vials featuring an external low-friction coating developed in partnership with Corning. This coating technology minimizes glass-to-glass and glass-to-metal contact during high-speed filling, improving pharmaceutical filling line efficiency by 20 to 50 percent and reducing line jams and breakages. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
In-Vitro Diagnostics Packaging Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Packaging Material | Glass, Plastics, Elastomers, Paper and Paperboard |
| Sterility Requirement | Sterile Packaging, Non-sterile Packaging |
| Supply Model | Standard Catalog Packaging, Customized Packaging, Contract Packaging |
In-Vitro Diagnostics Packaging Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Diagnostic Packaging Compliance Roadmap |
|
| Packaging Format Selection Strategies |
|
| Lab Workflow Packaging Optimization |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the in-vitro diagnostics packaging market?
What is the projected value of the in-vitro diagnostics packaging industry by 2036?
How are decentralized testing trends influencing diagnostic packaging requirements?
Why are advanced protective packaging systems becoming important for diagnostic supply chains?
Why do hospitals represent the largest end-user segment in the in-vitro diagnostics packaging market?
What is driving the rapid growth of oncology applications in the in-vitro diagnostics packaging market?
Why does North America lead the in-vitro diagnostics packaging market?
What is driving faster growth in Asia Pacific's diagnostics packaging market?
Who are the leading players in the in-vitro diagnostics packaging landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization